Literature DB >> 7587741

Expression of the Fas antigen in patients infected with human immunodeficiency virus.

T W McCloskey1, N Oyaizu, M Kaplan, S Pahwa.   

Abstract

Lymphocytes from patients with HIV infection have been shown to undergo accelerated apoptosis. Fas antigen is a cell surface protein known to initiate an apoptotic signal. Therefore, we undertook a study to examine the expression of the Fas antigen during HIV infection. Using three color flow cytometry, expression of the Fas antigen on lymphocytes of 23 HIV infected individuals (CDC category 2, CD4 200-499 cells/microL, n = 10; CDC category 3, CD4 < 200 cells/microL, n = 13) and 10 healthy controls was examined. Both CD3+CD4+ and CD3+CD8+ subsets were examined for their expression of this marker. In lymphocytes of healthy controls, 47% of the CD3+CD4+ and 45% of the CD3+CD8+ cells were Fas antigen positive. This percentage was significantly increased in CD4 cells from HIV infected patients belonging to CDC category 3, but was unchanged from normal values in CDC category 2 subjects. The increase in the percentage of CD4+ T cells expressing Fas antigen in patients correlated significantly with the decrease in circulating CD4 T cell count (P < 0.009). In addition, by examining mean fluorescence intensity, we found that the amount of Fas expression per cell was increased threefold in CD3+CD4+ cells and increased twofold in CD3+CD8+ cells in category 3 patients. These results demonstrate that an increase in Fas antigen expression occurs during HIV infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7587741     DOI: 10.1002/cyto.990220206

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  14 in total

1.  Early increase of CD4+ CD45RA+ and CD4+ CD95- cells with conserved repertoire induced by anti-retroviral therapy in HIV-infected patients.

Authors:  G Silvestri; C Munoz-Calleja; P Bagnarelli; G Piedimonte; M Clementi; M Montroni
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

2.  CD4+-T-cell counts, spontaneous apoptosis, and Fas expression in peripheral blood mononuclear cells obtained from human immunodeficiency virus type 1-infected subjects.

Authors:  A H Patki; D L Georges; M M Lederman
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

3.  CD95 expression and function on lymphocyte subpopulations in common variable immunodeficiency (CVID); related to increased apoptosis.

Authors:  J Iglesias; N Matamoros; S Raga; J M Ferrer; J Mila
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

Review 4.  Apoptosis in the heart: when and why?

Authors:  H J Brömme; J Holtz
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

5.  Concentrations of soluble CD95 and CD8 antigens in the plasma and levels of CD8+CD95+, CD8+CD38+, and CD4+CD95+ T cells are markers for HIV-1 infection and clinical status.

Authors:  J D Jiang; M Schlesinger; H Sacks; D Mildvan; J P Roboz; J G Bekesi
Journal:  J Clin Immunol       Date:  1997-03       Impact factor: 8.317

Review 6.  Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions.

Authors:  N Chirmule; S Pahwa
Journal:  Microbiol Rev       Date:  1996-06

7.  Increased expression of regeneration and tolerance factor in individuals with human immunodeficiency virus infection.

Authors:  B K DuChateau; G W Lee; M P Westerman; K D Beaman
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

8.  Fas (CD95) expression and death-mediating function are induced by CD4 cross-linking on CD4+ T cells.

Authors:  J Desbarats; J H Freed; P A Campbell; M K Newell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

9.  Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human T cells.

Authors:  Hubert Arokium; Masakazu Kamata; Irvin Chen
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

Review 10.  Role of apoptosis in HIV disease pathogenesis.

Authors:  N Oyaizu; S Pahwa
Journal:  J Clin Immunol       Date:  1995-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.